Evidence map›Paper›PMID 34751491›Full record

ArticleDermatologic therapy2022

Sudden onset of vitiligo after COVID-19 vaccine.

Giulia Ciccarese, Francesco Drago, Samuele Boldrin, Matilde Pattaro, Aurora Parodi

Abstract readLetter
In one paragraph

Article in Dermatologic therapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Exposome Risk Factors for Vitiligo: A Systematic Evidence Review.American journal of clinical dermatology · 2026
    Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Newly-developed vitiligo following COVID-19 mRNA vaccine.Journal of cosmetic dermatology · 2022
    Article
  18. Article
  19. Article
  20. New-onset vitiligo following COVID-19 disease.Skin health and disease · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Giulia CiccareseDermatology Clinic, Ospedale Policlinico San Martino, Genoa, Italy.ORCID 0000-0001-8363-0195
Francesco DragoDermatology Clinic, Ospedale Policlinico San Martino, Genoa, Italy.
Samuele BoldrinDI.S.Sal., Section of Dermatology, University of Genoa, Genoa, Italy.
Matilde PattaroDI.S.Sal., Section of Dermatology, University of Genoa, Genoa, Italy.
Aurora ParodiDermatology Clinic, Ospedale Policlinico San Martino, Genoa, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19HypopigmentationVitiligoAge of OnsetCOVID-19 VaccinesHumansSARS-CoV-2COVID-19 Vaccines

Identifiers

PMID34751491
PMCPMC8646249

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.